Because the double transgenic mouse model represents a model of over-expression, Chen et al. evaluated the inhibition of mutated Htt via miR-196a by transfecting induced pluripotent stem cells derived from individuals with HD (HD-iPSCs) with lentiviral vector encoding for miR-196a. This evidence concerns the gene HTT and Huntington disease.